Cell Line Development for Biologics

Automated Solutions for Cell Line Development

From producing cutting-edge vaccines to developing antibody drug conjugates to treat cancer, the use of cell lines to develop and produce drugs is changing all facets of the biopharma industry. Cell line development is no simple task. It’s a critical cog in the biologics production wheel.

Despite advances in technology, manual bottlenecks still plague this workflow. Putting a lifesaving biologic, such as a targeted monoclonal antibody, on the market requires years of drug discovery research, development, clinical trials and scaling up for commercialization. Beckman Coulter Life Sciences is more than an instrument solution provider.

Our experts in cell line development can help answer your questions and work with you on a customized solution that’ll transform your cell line development workflow into a nimble, efficient and results-driven enterprise.


                     

VECTOR CONSTRUCTION

STABLE TRANSFECTION

SINGLE-CELL DEPOSITION
AND MONOCLONALITY

CELL LINE
OPTIMIZATION

CLONE STABILITY

MASTER CELL BANKING

Design and produce a vector for protein expression. Transfect cells with a vector, integrating into genome. Singly deposit clones into culture and image to verify monoclonality. Test and select clones based on product analyses. Study for stable production across many generations. Cryopreserve successful lines for future development.
 

 

Learn More About Our Solutions For Cell Line Development

 


Learn More With Our Resources

Cell Line Development –
Hit Picking

 

Read Now

Automating
Cell Line Development

Read Now

Automating
Cell-Based Processes

 

Read Now

Cell Line Development –
Selection and Enrichment

 

Read Now

Cell Line Development –
Limiting Dilution

 

Read Now

Cell Line Development
for Hybridoma

 

Read Now

Automated determination
of cell concentration and viability

 

Read Now

 

Watch A Story About Developing Scalable, High-Yielding CHO Cell Lines

cell line development webinar by excellgene using the valita titer assay

Thanks in part to the Valita Titer assay, ExcellGene—a Swiss biologics CDMO—was able to develop scalable, high-yielding (4-8 g/L) Chinese hamster ovary (CHO) cell lines in just eight weeks.

Watch as ExcellGene’s Dr. Joeri Kint explains how being able to measure IgG directly in cell suspension and go straight from culture to plates and results is enabling them to rapidly select high-producing clones.

Watch Now

 

Want To Bring Your Cell Line Development Workflow To The Next Level?

Tell us a bit about yourself and what you would like to achieve.
Our experts will be in touch soon.